EP1317244A2 - Calcium carbonate compositions for use in the manufacture of toothpaste - Google Patents
Calcium carbonate compositions for use in the manufacture of toothpasteInfo
- Publication number
- EP1317244A2 EP1317244A2 EP01956221A EP01956221A EP1317244A2 EP 1317244 A2 EP1317244 A2 EP 1317244A2 EP 01956221 A EP01956221 A EP 01956221A EP 01956221 A EP01956221 A EP 01956221A EP 1317244 A2 EP1317244 A2 EP 1317244A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- suspension
- calcium carbonate
- weight
- aqueous
- suspension according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title claims abstract description 101
- 229910000019 calcium carbonate Inorganic materials 0.000 title claims abstract description 42
- 229940034610 toothpaste Drugs 0.000 title claims abstract description 25
- 239000000606 toothpaste Substances 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 239000000725 suspension Substances 0.000 claims abstract description 80
- 239000003755 preservative agent Substances 0.000 claims abstract description 28
- 239000002270 dispersing agent Substances 0.000 claims abstract description 27
- 239000007900 aqueous suspension Substances 0.000 claims abstract description 19
- 239000007787 solid Substances 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 6
- 239000012736 aqueous medium Substances 0.000 claims abstract description 5
- 238000011109 contamination Methods 0.000 claims abstract description 5
- 230000009969 flowable effect Effects 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 230000002906 microbiologic effect Effects 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 8
- 238000006385 ozonation reaction Methods 0.000 claims description 7
- 239000004115 Sodium Silicate Substances 0.000 claims description 5
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 5
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 5
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 5
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000009928 pasteurization Methods 0.000 claims description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 2
- 238000011169 microbiological contamination Methods 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 17
- 238000003860 storage Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 239000002002 slurry Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 235000011116 calcium hydroxide Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to calcium carbonate compositions, especially for use in the manufacture of toothpaste compositions.
- calcium carbonate especially precipitated calcium carbonate (PCC) a chemically synthesized form of this product, is presently supplied to toothpaste industries as a dry powder.
- PCC precipitated calcium carbonate
- this product in this form causes a series of problems, such as: a) Emlubrious conditions at the production site, owing to the presence of large amounts of powder; b) the need to use paper bags to contain and store the powder; c) low productivity rates, owing to the time spent in the addition of powdered carbonate to other ingredients in the toothpaste manufacturing process; d) the need to keep a large storage ofthe product close to the toothpaste manufacturing plant; and e) extensive handling of the product during the processing stages, increasing the risk of causing microbiological contamination in the final product.
- the purpose of the present invention is to provide a an aqueous slurry or suspension of calcium carbonate which is suitable for use in the toothpaste industry.
- an aqueous suspension of particulate calcium carbonate for use in the manufacture of toothpaste compositions which includes, in addition to the calcium carbonate, one or more dispersing agents and/or one or more preservative agents and wherein the aqueous medium of the suspension has been treated so that the biological contamination of the suspension is not greater than the maximum allowable levels indicated by the US Food and Drugs Administration (FDA), for example standards set by Food and Chemical Codex and United States Pharmacopea.
- FDA US Food and Drugs Administration
- the suspension according to the invention may be a high solids suspension which is pumpable and flowable.
- the solids content of the suspension may be 50% or more, in many cases 60% or more, e.g. up to 80% or more, by weight.
- the viscosity may be 1000m Pa.s or less, e.g. 700mPa.s or less, especially from lOOmPa.s to 500mPa.s.
- the suspension according to the invention meets these requirements as they are presently expressed, and which are incorporated here for the first time of a calcium carbonate suitable for use in toothpaste industry in aqueous suspension form has several benefits. The problems described earlier are reduced or avoided. In addition, since the toothpaste manufacturing process requires large amounts of water for the addition ofthe other components ofthe toothpaste composition, and the calcium carbonate can be easily delivered from a storage tank to the manufacturing site by pumping, the aqueous suspension form is well suited to the toothpaste manufacturing process.
- the calcium carbonate employed in the suspension according to the invention may be a PCC although it could alternatively be a product processed from naturally occurring sources, generally by procedures involving grinding, i.e. a ground calcium carbonate or 'GCC.
- the calcium carbonate may have an impurity content of not greater than 5%, preferably not greater than 3%, by weight.
- the calcium carbonate, if a PCC may be prepared by any well known process. For example, PCC may be produced by carbonating an aqueous suspension of calcium hydroxide by addition of carbon dioxide.
- the dispersing agent employed in the suspension according to one aspect of the invention may be any art recognized agent that is able to sufficiently disperse and reduce the viscosity of the suspension of calcium carbonate.
- the dispersing agent comprises one or more inorganic or organic agents known in the art.
- the dispersing agent comprises one or more sodium salts.
- the agent may, for example, comprise one or more of: a condensed phosphate salt, such as sodium hexametaphosphate; a silicate, e.g. sodium silicate; and mixtures thereof.
- the total amount of dispersing agent(s) employed may be from 0.1% to 6%, e.g. from 0.5% to 2%, by weight active based on the dry weight of calcium, carbonate.
- a particularly suitable dispersing agent is a mixture of sodium silicate, 0.5% to 2.0%, preferably 0.8% to 1.2%, active by weight, and sodium hexametaphosphate, 0.1% to 0.7%, preferably 0.3% to 0.5%, active by weight, the weights being based on the dry weight of calci rn . carbonate.
- the dispersing agent may alternatively or in addition comprise any surface-modifying agent which will disperse the PCC in the slurry, such ⁇ s surfactants or tensio-active agents.
- the preservative agent employed in the suspension according to o ⁇ e aspect of the invention may be any substance known to inhibit microbiologies growth.
- the agent to be used may be chosen from any preservatives known i n the art.
- the preservative agent may comprise one or more of; an inorganic oxidizing preservative agent, such as sodium hypochlorite; a simple organic preservative agent, such as formaldehyde; or mixtures thereof.
- the total amount of preservative agent present in the suspension may be at least 0.005%, e.g. from 0.01% to 0.20%, especially from 0.01% to 0.10%, active based on the total suspension weight.
- the calcium carbonate when in PCC form may be prepared in any well known manner, for example by carbonation of lime, e.g. by reaction of gaseous carbon dioxide with slaked lime in an aqueous suspension.
- the particles of the PCC may be in any form known in the art to be useful in toothpaste compositions.
- the PCC particles may be in the rhombohedral or aragonite crystal form.
- the aqueous suspension according to one aspect of the invention may be prepared as follows.
- a starting suspension of particulate calcium carbonate e.g. a dilute PCC suspension formed following carbonation and neutralization having a solids content of not more than 40% by weight, e.g. from 10% to 30% by weight, is de watered using any art recognized method.
- a press filter or similar equipment may be employed.
- a solids content of at least 50% by weight is obtained through dewatering.
- a cake may be produced.
- the particles of the cake are then dispersed by addition of a dispersing agent.
- mechanical agitation e.g. a high speed stirrer, is used to aid dispersion.
- the dispersion may be carried out in a suitable vessel such as a dispersion vessel, a blender or dissolver.
- the dispersing agent which may comprise one or more suitable dispersant compounds, may be added in an amount sufficient to reduce the viscosity of the suspension to an appropriate value as defined earlier, suitable for its use in the toothpaste formulation.
- One or more preservative agents may be added to the suspension to control or inhibit the development of microbiological contaminants in the suspension.
- a preservative agent such as sodium hypochlorite in the form of an aqueous solution is preferably employed as the preservative agent to be added to the suspension.
- Water which has been treated by a process which inhibits microbiological growth may preferably be added to the suspension. The water may conveniently be that in which the dispersing agent or the preservative additive or preferably both is contained.
- the treatment of the water to inhibit microbiological growth may be performed after the addition of the water to the calcium carbonate, so that the entire calcium carbonate suspension is treated.
- the water may be treated by any known sterilization technique which will sufficiently reduce the microbiological activity level of the water.
- the water may be treated using one or more of the following: known ultra high temperature treatments; sterilization; pasteurization; ozonation; or other processes known to reduce microbiological activity therein to an FDA accepted level.
- the water is treated by ozonation.
- the suspension product after addition of the dispersing agent and the preservative agent may be transferred to a storage tank.
- the suspension is left in the storage tank for a time sufficient to allow the amount of ozone remaining in the suspension to drop to acceptable levels.
- the suspension is left for at least forty eight hours in the storage tank to allow active ozone to be eliminated to the fullest extent possible.
- the suspension may be delivered to a toothpaste manufacturing plant by pumping (if the plant is local), by transport on a vehicle such as a slurry tanker, or by any other transport method.
- the suspension may, after treatment as described above, optionally be further treated in a known manner to give a further concentrated product. This may be carried out through further dewatering or drying, e.g. using a vacuum or press cleaner and/or a dryer. Following such treatment, a solids content of up to 99.5%o by weight may be obtained.
- a method of producing an aqueous suspension of calcium carbonate as described above wherein a dispersing agent and a preservative agent are added to a suspension of calcium carbonate and then water which has been treated by a process to reduce microbiological activity therein is added to the suspension.
- the dispersing agent and the preservative agent may be added to the suspension as a solution together with the treated water.
- the dispersing agent, preservative agent, untreated water, and calcium carbonate may be combined and then treated by one of the methods disclosed above.
- Example 50 tonnes of a (predominantly rhombohedral) PCC in an aqueous suspension having a 20% by weight solids content was prepared.
- the PCC had a minimum CaC03 content of 98.0%>, i.e. not greater than 2% by weight of impurities, by weight and whiteness of 97%o.
- the PCC suspension was filtered in a press filter, generating 14.285 tonnes of cake having a 70% solids concentration.
- the cake was transported to a storage silo and afterwards transferred ready for addition to a dispersion vessel having a capacity of 2000 litres and fitted with a stirrer operating at a speed of 1500 rpm. 236 kg of an aqueous solution which had been pre-treated as described below was added to and mixed with 3,064.26 kg of the PCC cake in the vessel.
- the solution added to the vessel contained as additives (i) sodium silicate in an active amount of 1.0%) based on the dry weight of PCC present; (ii) sodium hexametaphosphate in active amount of 0.4% by weight based on the dry weight of the PCC present and (iii) sodium hypochlorite preservative agent in an active amount of 0.015%) by weight based on the total suspension weight.
- the base water employed to provide the solution containing the additives (i), (ii) and (iii) was previously ozonated for one hour, to achieve a solution meeting current international microbiological control standards. This pre-ozonated solution still contained active ozone when it was added to and mixed with the PCC cake.
- the contents of the dispersion vessel were stirred for about one hour to ensure complete dispersion of the PCC. After that period, the obtained suspension had a viscosity of 250 mPa.s (measured by the well known o
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
An aqueous suspension of particulate calcium carbonate for use in the manufacture of toothpaste compositions includes in addition to the calcium carbonate one or more dispersing agents and one or more preservative agents and wherein the aqueous medium of the suspension has been treated so that the biological contamination of the suspension is not greater than the maximum allowable levels indicated by the US Food and Drugs Administration (FDA). The calcium carbonate may comprise a precipitated and/or ground calcium carbonate. The suspension may have a solids content of from 50 % to 99.5 % by weight. The suspension may be flowable and pumpable.
Description
CALCIUM CARBONATE COMPOSITIONS
The present invention relates to calcium carbonate compositions, especially for use in the manufacture of toothpaste compositions. Utilized as a polishing agent in toothpaste formulations, calcium carbonate, especially precipitated calcium carbonate (PCC) a chemically synthesized form of this product, is presently supplied to toothpaste industries as a dry powder. Using this product in this form causes a series of problems, such as: a) insalubrious conditions at the production site, owing to the presence of large amounts of powder; b) the need to use paper bags to contain and store the powder; c) low productivity rates, owing to the time spent in the addition of powdered carbonate to other ingredients in the toothpaste manufacturing process; d) the need to keep a large storage ofthe product close to the toothpaste manufacturing plant; and e) extensive handling of the product during the processing stages, increasing the risk of causing microbiological contamination in the final product.
Calcium carbonate is already supplied to other industries, e.g. the paint and paper industries, in aqueous slurry form. However, the slurries available would not be suitable for use in the toothpaste industry. The purpose of the present invention is to provide a an aqueous slurry or suspension of calcium carbonate which is suitable for use in the toothpaste industry.
According to one embodiment ofthe present invention there is provided an aqueous suspension of particulate calcium carbonate for use in the manufacture of toothpaste compositions which includes, in addition to the calcium carbonate, one or more dispersing agents and/or one or more preservative agents and wherein the aqueous medium of the suspension has been treated so that the biological contamination of the suspension is not
greater than the maximum allowable levels indicated by the US Food and Drugs Administration (FDA), for example standards set by Food and Chemical Codex and United States Pharmacopea.
All numerical values and ranges recited herein are to be understood as modified by the term "about," unless otherwise noted.
The suspension according to the invention may be a high solids suspension which is pumpable and flowable. The solids content of the suspension may be 50% or more, in many cases 60% or more, e.g. up to 80% or more, by weight. When measured by the Brookfield method using a Spindle 3 at 25°C, the viscosity may be 1000m Pa.s or less, e.g. 700mPa.s or less, especially from lOOmPa.s to 500mPa.s.
All the raw materials used by the toothpaste industry must be food grade, that is, they must fulfill certain conditions demanded by various authorities which control the industry, especially the FDA. In particular, microbiological control levels of the raw materials must be compatible with those set for the pharmaceutical and food industries indicated by the FDA. The suspension according to the invention meets these requirements as they are presently expressed, and which are incorporated here for the first time of a calcium carbonate suitable for use in toothpaste industry in aqueous suspension form has several benefits. The problems described earlier are reduced or avoided. In addition, since the toothpaste manufacturing process requires large amounts of water for the addition ofthe other components ofthe toothpaste composition, and the calcium carbonate can be easily delivered from a storage tank to the manufacturing site by pumping, the aqueous suspension form is well suited to the toothpaste manufacturing process.
The calcium carbonate employed in the suspension according to the invention may be a PCC although it could alternatively be a product processed
from naturally occurring sources, generally by procedures involving grinding, i.e. a ground calcium carbonate or 'GCC. The calcium carbonate may have an impurity content of not greater than 5%, preferably not greater than 3%, by weight. The calcium carbonate, if a PCC, may be prepared by any well known process. For example, PCC may be produced by carbonating an aqueous suspension of calcium hydroxide by addition of carbon dioxide.
The dispersing agent employed in the suspension according to one aspect of the invention may be any art recognized agent that is able to sufficiently disperse and reduce the viscosity of the suspension of calcium carbonate. In one embodiment, the dispersing agent comprises one or more inorganic or organic agents known in the art. Preferably, the dispersing agent comprises one or more sodium salts. The agent may, for example, comprise one or more of: a condensed phosphate salt, such as sodium hexametaphosphate; a silicate, e.g. sodium silicate; and mixtures thereof. The total amount of dispersing agent(s) employed may be from 0.1% to 6%, e.g. from 0.5% to 2%, by weight active based on the dry weight of calcium, carbonate. We have found that a particularly suitable dispersing agent is a mixture of sodium silicate, 0.5% to 2.0%, preferably 0.8% to 1.2%, active by weight, and sodium hexametaphosphate, 0.1% to 0.7%, preferably 0.3% to 0.5%, active by weight, the weights being based on the dry weight of calci rn. carbonate. The dispersing agent may alternatively or in addition comprise any surface-modifying agent which will disperse the PCC in the slurry, such ^s surfactants or tensio-active agents.
The preservative agent employed in the suspension according to oηe aspect of the invention may be any substance known to inhibit microbiologies growth. The agent to be used may be chosen from any preservatives known in the art. For example, the preservative agent may comprise one or more of; an
inorganic oxidizing preservative agent, such as sodium hypochlorite; a simple organic preservative agent, such as formaldehyde; or mixtures thereof. The total amount of preservative agent present in the suspension may be at least 0.005%, e.g. from 0.01% to 0.20%, especially from 0.01% to 0.10%, active based on the total suspension weight.
The calcium carbonate when in PCC form may be prepared in any well known manner, for example by carbonation of lime, e.g. by reaction of gaseous carbon dioxide with slaked lime in an aqueous suspension. The particles of the PCC may be in any form known in the art to be useful in toothpaste compositions. For example, the PCC particles may be in the rhombohedral or aragonite crystal form.
The aqueous suspension according to one aspect of the invention may be prepared as follows. A starting suspension of particulate calcium carbonate, e.g. a dilute PCC suspension formed following carbonation and neutralization having a solids content of not more than 40% by weight, e.g. from 10% to 30% by weight, is de watered using any art recognized method. In one embodiment, a press filter or similar equipment may be employed. Preferably, a solids content of at least 50% by weight is obtained through dewatering. Alternatively, a cake may be produced. The particles of the cake are then dispersed by addition of a dispersing agent. Preferably, mechanical agitation, e.g. a high speed stirrer, is used to aid dispersion. The dispersion may be carried out in a suitable vessel such as a dispersion vessel, a blender or dissolver.
The dispersing agent, which may comprise one or more suitable dispersant compounds, may be added in an amount sufficient to reduce the viscosity of the suspension to an appropriate value as defined earlier, suitable for its use in the toothpaste formulation. One or more preservative agents may
be added to the suspension to control or inhibit the development of microbiological contaminants in the suspension. A preservative agent such as sodium hypochlorite in the form of an aqueous solution is preferably employed as the preservative agent to be added to the suspension. Water which has been treated by a process which inhibits microbiological growth may preferably be added to the suspension. The water may conveniently be that in which the dispersing agent or the preservative additive or preferably both is contained. Alternatively, the treatment of the water to inhibit microbiological growth may be performed after the addition of the water to the calcium carbonate, so that the entire calcium carbonate suspension is treated. The water may be treated by any known sterilization technique which will sufficiently reduce the microbiological activity level of the water. For example, the water may be treated using one or more of the following: known ultra high temperature treatments; sterilization; pasteurization; ozonation; or other processes known to reduce microbiological activity therein to an FDA accepted level. Preferably, the water is treated by ozonation.
The suspension product after addition of the dispersing agent and the preservative agent may be transferred to a storage tank. Where water contained in the suspension has been treated by ozonation, the suspension is left in the storage tank for a time sufficient to allow the amount of ozone remaining in the suspension to drop to acceptable levels. Preferably, the suspension is left for at least forty eight hours in the storage tank to allow active ozone to be eliminated to the fullest extent possible. Following such storage the suspension may be delivered to a toothpaste manufacturing plant by pumping (if the plant is local), by transport on a vehicle such as a slurry tanker, or by any other transport method.
The suspension may, after treatment as described above, optionally be further treated in a known manner to give a further concentrated product. This may be carried out through further dewatering or drying, e.g. using a vacuum or press cleaner and/or a dryer. Following such treatment, a solids content of up to 99.5%o by weight may be obtained.
In another aspect of the present invention, there is provided a method of producing an aqueous suspension of calcium carbonate as described above wherein a dispersing agent and a preservative agent are added to a suspension of calcium carbonate and then water which has been treated by a process to reduce microbiological activity therein is added to the suspension.
In another embodiment, the dispersing agent and the preservative agent may be added to the suspension as a solution together with the treated water.
Alternatively, the dispersing agent, preservative agent, untreated water, and calcium carbonate may be combined and then treated by one of the methods disclosed above.
Embodiments of the present invention will now be described by way of example only with reference to the following Example.
Example 50 tonnes of a (predominantly rhombohedral) PCC in an aqueous suspension having a 20% by weight solids content was prepared. The PCC had a minimum CaC03 content of 98.0%>, i.e. not greater than 2% by weight of impurities, by weight and whiteness of 97%o. The PCC suspension was filtered in a press filter, generating 14.285 tonnes of cake having a 70% solids concentration.
The cake was transported to a storage silo and afterwards transferred ready for addition to a dispersion vessel having a capacity of 2000 litres and
fitted with a stirrer operating at a speed of 1500 rpm. 236 kg of an aqueous solution which had been pre-treated as described below was added to and mixed with 3,064.26 kg of the PCC cake in the vessel. The solution added to the vessel contained as additives (i) sodium silicate in an active amount of 1.0%) based on the dry weight of PCC present; (ii) sodium hexametaphosphate in active amount of 0.4% by weight based on the dry weight of the PCC present and (iii) sodium hypochlorite preservative agent in an active amount of 0.015%) by weight based on the total suspension weight. The base water employed to provide the solution containing the additives (i), (ii) and (iii) was previously ozonated for one hour, to achieve a solution meeting current international microbiological control standards. This pre-ozonated solution still contained active ozone when it was added to and mixed with the PCC cake.
The contents of the dispersion vessel were stirred for about one hour to ensure complete dispersion of the PCC. After that period, the obtained suspension had a viscosity of 250 mPa.s (measured by the well known o
Brookfield method using a Spindle 3, at 25 C). This suspension was kept in storage tanks for a period of forty-eight hours until there had been complete elimination of the active ozone from the suspension before delivery of the suspension to a toothpaste production plant.
Claims
1. An aqueous suspension of particulate calcium carbonate for use in the manufacture of toothpaste compositions wherein the biological contamination of the suspension is not greater than the maximum allowable levels indicated by the US Food and Drugs Administration (FDA).
2. An aqueous suspension of particulate calcium carbonate for use in the manufacture of toothpaste compositions wherein the aqueous medium has been treated so that the biological contamination of the suspension is not greater than the maximum allowable levels indicated by the US Food and Drugs Administration (FDA).
3. An aqueous suspension according to claims 1 or 2 wherein the suspension further comprises one or more dispersing agents.
4. An aqueous suspension according to claims 1 or 2 wherein the suspension further comprises one or more preservative agents.
5. An aqueous suspension for use in the manufacture of toothpaste compositions comprising: particulate calcium carbonate; one or more dispersing agents; and one or more preservative agents; wherein the aqueous medium has been treated so that the biological contamination of the suspension is not greater than the maximum allowable levels indicated by the US Food and Drugs Administration (FDA).
6. A suspension according to any ofthe preceding claims wherein the calcium carbonate comprises a precipitated and/or ground calcium carbonate.
7. A suspension according to any of the preceding claims wherein the calcium carbonate has an impurity content not greater than 5% by weight.
8. A suspension according to claim 7 wherein the calcium carbonate has an impurity content not greater than 3%> by weight.
9. A suspension according to any one of the preceding claims wherein the solids content ofthe suspension is from 50% to 99.5% by weight.
10. A suspension according to claim 9 wherein the solids content of the suspension is from 80% to 99.5%> by weight.
11. A suspension according to any one of the preceding claims wherein the suspension is flowable and/or pumpable.
12. A suspension according to any one of the preceding claims wherein the suspension has a viscosity of not greater than lOOOmPa.s.
13. A suspension according to claim 12 wherein the suspension has a viscosity of from lOOmPa.s to 500mPa.s.
14. A suspension according to any of claims 3 or 5 to 13 wherein the dispersing agent comprises one or more sodium salts.
15. A suspension according to any of claims 3 or 5 to 13 wherein the dispersing agent comprises a condensed phosphate and/or a silicate.
16. A suspension according to claim 15 wherein the dispersing agent comprises from 0.1% to 0.7% active by weight of sodium hexametaphosphate and from 0.5% to 2.0% by weight of sodium silicate, the weights being based on the dry weight of calcium carbonate present.
17. A suspension according to claim 16 wherein the dispersing agent comprises from 0.3% to 0.5% active by weight of sodium hexametaphosphate and from 0.8% to 1.2% active by weight of sodium silicate, the weights being based on the dry weight of calcium carbonate present.
18. A suspension according to any of claims 4 to 17 wherein the preservative agent comprises an oxidizing inorganic chemical or a simple organic chemical.
19. A suspension according to claim 18 wherein the preservative agent comprises sodium hypochlorite or fonnaldehyde.
20. A suspension according to claim 18 or claim 19 wherein the amount of preservative agent present is from 0.005%> to 0.2% by weight based on the total suspension weight.
21. A suspension according to claim 20 wherein the amount of preservative agent present is from 0.01% to 0.1% by weight based on the total weight of the suspension.
22. A suspension according to any one of the preceding claims wherein the aqueous medium of the suspension has been treated by a process to reduce microbiological activity therein.
23. A suspension according to claim 22 wherein the treatment process comprises a sterilization, pasteurization or ozonation process, or a combination thereof.
24. A suspension according to claim 23 wherein the treatment process comprises ozonation.
25. A method of producing an aqueous suspension of calcium carbonate for use in the manufacture of toothpaste compositions comprising: adding a dispersing agent and a preservative agent to a suspension of calcium carbonate; and adding to the suspension water that has been treated by a process to reduce microbiological activity therein.
26. A method of producing an aqueous suspension of calcium carbonate for use in the manufacture of toothpaste compositions comprising: providing an aqueous solution of water, a dispersing agent and a preservative agent; and adding to a suspension of calcium carbonate the aqueous solution of water; wherein the water has been treated by a process to reduce microbiological activity therein.
27. A method according to claims 25 or 26 wherein the suspension prior to addition of the dispersing agent and the preservative agent is dewatered to have a solids content of at least 50% by weight.
28. A method according to claim 27 wherein the suspension is dewatered to produce a cake.
29. A method of producing an aqueous suspension of calcium carbonate for use in the manufacture of toothpaste compositions comprising: providing an aqueous suspension of calcium carbonate containing a dispersing agent and a preservative agent; and treating the aqueous suspension by a process to reduce the microbiological activity therein.
30. A method according to claims 25 to 29 wherein the microbiological activity such that the microbiological contamination of the suspension is not greater than the maximum allowable levels indicated by the US Food and
Drugs Administration (FDA).
31. A method according to claims 25 to 30 wherein the treatment process comprises a sterilization, pasteurization or ozonation process, or a combination thereof.
32. A method according to claim 31 wherein the treatment process comprises an ozonation process.
33. A method according to any one of claims 25 to 32 wherein the suspension is dewatered following addition of the dispersing agent and the preservative agent.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0020183 | 2000-08-17 | ||
| GB0020183A GB0020183D0 (en) | 2000-08-17 | 2000-08-17 | Calcium carbonate compositions |
| PCT/BR2001/000101 WO2002013774A2 (en) | 2000-08-17 | 2001-08-17 | Calcium carbonate compositions for use in the manufacture of toothpaste |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1317244A2 true EP1317244A2 (en) | 2003-06-11 |
Family
ID=9897730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP01956221A Withdrawn EP1317244A2 (en) | 2000-08-17 | 2001-08-17 | Calcium carbonate compositions for use in the manufacture of toothpaste |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1317244A2 (en) |
| AU (1) | AU2001278314A1 (en) |
| BR (1) | BR0113336A (en) |
| CA (1) | CA2414440A1 (en) |
| GB (1) | GB0020183D0 (en) |
| WO (1) | WO2002013774A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004087087A1 (en) * | 2003-04-04 | 2004-10-14 | Unilever N.V. | Process for the manufacture of an oral composition |
| FR2881064A1 (en) * | 2005-01-26 | 2006-07-28 | Omya Development Ag | Disinfecting, conserving, reducing and/or controlling microbial contamination of aqueous dispersions and/or suspensions of mineral materials comprises increasing the concentration of hydroxyl ions and dispersing/crushing the suspensions |
| MX2017006825A (en) | 2014-12-01 | 2017-09-27 | Colgate Palmolive Co | Use of ozone to control bioburden in precipitated calcium carbonate slurry (pcc). |
| DE102018008666A1 (en) * | 2018-11-05 | 2020-05-07 | Brillux Gmbh & Co. Kg | Process for preserving a dispersion in a dosing system and dosing system |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2562488A (en) * | 1947-10-06 | 1951-07-31 | Bactericidal Res Inc | Germicidal reaction products of silver salts and monohydroxy-monoamino alkanes |
| US5716629A (en) * | 1996-08-08 | 1998-02-10 | Nalco Chemical Company | Synergistic blend of 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane tetrahydro-3,5,-dimethyl-2h-1,3,5-thiadiazine-2-thione |
| US6149894A (en) * | 1999-05-14 | 2000-11-21 | Colgate Palmolive Company | Method for the manufacture of toothpaste |
-
2000
- 2000-08-17 GB GB0020183A patent/GB0020183D0/en not_active Ceased
-
2001
- 2001-08-17 AU AU2001278314A patent/AU2001278314A1/en not_active Abandoned
- 2001-08-17 BR BR0113336-5A patent/BR0113336A/en not_active Application Discontinuation
- 2001-08-17 CA CA002414440A patent/CA2414440A1/en not_active Abandoned
- 2001-08-17 EP EP01956221A patent/EP1317244A2/en not_active Withdrawn
- 2001-08-17 WO PCT/BR2001/000101 patent/WO2002013774A2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0213774A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001278314A1 (en) | 2002-02-25 |
| WO2002013774A8 (en) | 2004-04-08 |
| CA2414440A1 (en) | 2002-02-21 |
| BR0113336A (en) | 2004-02-17 |
| WO2002013774A3 (en) | 2002-06-13 |
| WO2002013774A2 (en) | 2002-02-21 |
| GB0020183D0 (en) | 2000-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7861955B2 (en) | Wet-grinding gypsum with polycarboxylates | |
| FI78888B (en) | MINERALPARTIKLAR I SUSPENSION INNEHAOLLANDE KOMPOSITIONER OCH FOERFARANDE FOER BEHANDLING AV VATTENSYSTEM MED DEM. | |
| US4888160A (en) | Process for producing calcium carbonate and products thereof | |
| EP0850685B1 (en) | Method of producing dispersed aqueous suspensions | |
| EP0697996B1 (en) | Stabilized magnesium hydroxide slurry | |
| RU2630795C2 (en) | Lime-and-magnesium suspension, which is convenient in use | |
| CA2230158A1 (en) | Acid resistant calcium carbonate composition and uses therefor | |
| US5647902A (en) | Stabilized calcium carbonate composition using sodium carbonate and mixtures of acids and uses therefor | |
| US5593489A (en) | Acid resistant carbonate composition containing an aluminum or magnesium hydroxide methods of preparation and uses therefor | |
| TWI498288B (en) | Stabilisation of aqueous mineral preparations by reuterin | |
| EP1317244A2 (en) | Calcium carbonate compositions for use in the manufacture of toothpaste | |
| EP0804384B1 (en) | Process for producing stabilized magnesium hydroxyde slurries | |
| CN113582320A (en) | Preparation and application of alkaline calcium-based product with anti-settling property | |
| FI90758C (en) | Method for forming finely divided calcium sulfate | |
| JP2562543B2 (en) | How to prevent red water from tap water | |
| JP3786717B2 (en) | Method for preparing calcium carbonate dispersion | |
| US10450209B2 (en) | Stable salt-free polyaluminum chlorosulfates | |
| US7105139B2 (en) | Stabilization of the viscosity of formamidine sulfinic acid bleached calcium carbonate slurries | |
| KR100644152B1 (en) | Composition of Calcium Ingredient for Food Additives | |
| US4710226A (en) | Fluidization of limestone slurries and resultant products | |
| US20040237845A1 (en) | Stabilized chlorine dioxide as oxidizing agent for use in pulp | |
| EP4299533A1 (en) | A method for treating wastewaters from anaerobic digestion, a system for treating wastewaters, use of dry lime composition and a fertilizer product | |
| JP2965542B2 (en) | Calcium carbonate emulsion for food | |
| FI118799B (en) | Process for acidification and filtration of water | |
| WO2019148179A1 (en) | Stable salt-free polyaluminum chlorosulfates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20030115 |
|
| AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050301 |